Clustering of COPD patients and their response to pulmonary rehabilitation.


Journal

Respiratory medicine
ISSN: 1532-3064
Titre abrégé: Respir Med
Pays: England
ID NLM: 8908438

Informations de publication

Date de publication:
07 2022
Historique:
received: 26 11 2021
revised: 09 04 2022
accepted: 23 04 2022
pubmed: 14 5 2022
medline: 15 6 2022
entrez: 13 5 2022
Statut: ppublish

Résumé

Pulmonary rehabilitation (PR) is fundamental in the management of chronic obstructive pulmonary disease (COPD). COPD patients show a large clinical heterogeneity that may influence their response to PR. Identification of homogeneous clusters of patients who may or may not respond to PR is important to personalize patient care. This study aimed at identifying distinct clinical phenotypes of COPD patients and assessing their respective 6-min walking distance (6MWD) response to in-patient PR. This is a cohort-based analysis of COPD patients admitted to a PR center between January 2012 and December 2017. Pre-PR patients' characteristics, lung function and 6-min walking test parameters were introduced in a hierarchical ascending clustering approach to identify distinct clusters. Out of 835 patients, 4 distinctive clusters were identified. The most likely to show clinically significant 6MWD improvement post-PR (responders) were cluster 1 (younger men, GOLD I-II, average walkers, obese; non-response rate: 16%), cluster 2 (older women, GOLD II-III, slow walkers; 18%), and cluster 3 (older men, GOLD II-III, dyspneic, slow walkers; 11%). The most likely to be non-responders were cluster 4 (older men, GOLD III-IV, dyspneic, very slow walkers, oxygen-dependent; 26%). Our data identified homogeneous patient clusters representing clinically relevant subgroups of COPD patients regarding their 6MWD response to PR. Clusters having the largest probability of being non-responders were older, more severe, with severe oxygen desaturation and dyspnea, limited 6MWD and requiring long-term oxygen therapy. These results may improve patient phenotyping in clinical practice and allow individualization of therapy.

Sections du résumé

BACKGROUND AND OBJECTIVE
Pulmonary rehabilitation (PR) is fundamental in the management of chronic obstructive pulmonary disease (COPD). COPD patients show a large clinical heterogeneity that may influence their response to PR. Identification of homogeneous clusters of patients who may or may not respond to PR is important to personalize patient care. This study aimed at identifying distinct clinical phenotypes of COPD patients and assessing their respective 6-min walking distance (6MWD) response to in-patient PR.
METHODS
This is a cohort-based analysis of COPD patients admitted to a PR center between January 2012 and December 2017. Pre-PR patients' characteristics, lung function and 6-min walking test parameters were introduced in a hierarchical ascending clustering approach to identify distinct clusters.
RESULTS
Out of 835 patients, 4 distinctive clusters were identified. The most likely to show clinically significant 6MWD improvement post-PR (responders) were cluster 1 (younger men, GOLD I-II, average walkers, obese; non-response rate: 16%), cluster 2 (older women, GOLD II-III, slow walkers; 18%), and cluster 3 (older men, GOLD II-III, dyspneic, slow walkers; 11%). The most likely to be non-responders were cluster 4 (older men, GOLD III-IV, dyspneic, very slow walkers, oxygen-dependent; 26%).
CONCLUSION
Our data identified homogeneous patient clusters representing clinically relevant subgroups of COPD patients regarding their 6MWD response to PR. Clusters having the largest probability of being non-responders were older, more severe, with severe oxygen desaturation and dyspnea, limited 6MWD and requiring long-term oxygen therapy. These results may improve patient phenotyping in clinical practice and allow individualization of therapy.

Identifiants

pubmed: 35561651
pii: S0954-6111(22)00126-3
doi: 10.1016/j.rmed.2022.106861
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106861

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Yara Al Chikhanie (Y)

Cardiopulmonary Rehabilitation Center Dieulefit Santé, Dieulefit, France; Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.

Sébastien Bailly (S)

Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.

Ines Amroussa (I)

Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.

Daniel Veale (D)

Cardiopulmonary Rehabilitation Center Dieulefit Santé, Dieulefit, France; Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.

Frédéric Hérengt (F)

Cardiopulmonary Rehabilitation Center Dieulefit Santé, Dieulefit, France; Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France.

Samuel Verges (S)

Univ. Grenoble. Alpes, Inserm, CHU Grenoble Alpes, HP2, Grenoble, France. Electronic address: sverges@chu-grenoble.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH